NUDCD3 deficiency disrupts V(D)J recombination to cause SCID and Omenn syndrome.
Rui ChenElena LukianovaIna Schim van der LoeffJarmila Stremenova SpegarovaJoseph D P WilletKieran D JamesEdward J RyderHelen GriffinHanna IJspeertAkshada GajbhiyeFrederic LamoliatteJosé Luis Marín-RubioLisa WoodbineHenrique LemosDavid J SwanValeria PintarKamal SayesElias R Ruiz-MoralesSimon EasthamDavid DixonMartin PreteElena PrigmorePenny JeggoJoan BoyesAndrew L MellorLei HuangMirjam van der BurgKarin R EngelhardtAsbjørg Stray-PedersenHans Christian ErichsenAndrew R GenneryMatthias TrostDavid J AdamsGraham AndersonAnna LorencGosia TrynkaSophie HambletonPublished in: Science immunology (2024)
Inborn errors of T cell development present a pediatric emergency in which timely curative therapy is informed by molecular diagnosis. In 11 affected patients across four consanguineous kindreds, we detected homozygosity for a single deleterious missense variant in the gene NudC domain-containing 3 ( NUDCD3 ) . Two infants had severe combined immunodeficiency with the complete absence of T and B cells (T - B - SCID), whereas nine showed classical features of Omenn syndrome (OS). Restricted antigen receptor gene usage by residual T lymphocytes suggested impaired V(D)J recombination. Patient cells showed reduced expression of NUDCD3 protein and diminished ability to support RAG-mediated recombination in vitro, which was associated with pathologic sequestration of RAG1 in the nucleoli. Although impaired V(D)J recombination in a mouse model bearing the homologous variant led to milder immunologic abnormalities, NUDCD3 is absolutely required for healthy T and B cell development in humans.
Keyphrases
- dna repair
- dna damage
- mouse model
- case report
- end stage renal disease
- prognostic factors
- induced apoptosis
- genome wide
- copy number
- newly diagnosed
- ejection fraction
- chronic kidney disease
- public health
- poor prognosis
- healthcare
- binding protein
- emergency department
- patient safety
- squamous cell carcinoma
- oxidative stress
- gene expression
- genome wide identification
- lymph node
- bone marrow
- stem cells
- autism spectrum disorder
- mesenchymal stem cells
- single molecule
- quality improvement
- emergency medical